Skip to main content
Livermore
Livermore
ZHEN

Renaissance Technologies LLC

SEC CIK
0001037389
Latest filing
Aug 13, 2026

CBIO holding history

Crescent Biopharma, Inc. in every 13F filed by Renaissance Technologies LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CBIO overviewAll 13F holders of CBIOFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
19
Since Q1 2021
Holdings of CBIO by Renaissance Technologies LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−24,262−100.0%Sold outHolders
Q1 202624,262$445.7K<0.1%−22,438−48.0%ReducedHolders
Q4 202546,700$553.9K<0.1%+19,800+73.6%AddedHolders
Q3 202526,900$319.8K<0.1%+26,900NewHolders
Q1 20250$00.0%−41,153−100.0%Sold outHolders
Q4 202441,153$10.2K<0.1%−739,947−94.7%ReducedHolders
Q3 2024781,100$132.0K<0.1%−45,751−5.5%ReducedHolders
Q2 2024826,851$232.8K<0.1%+685,151+483.5%AddedHolders
Q1 2024141,700$425.0K<0.1%+17,256+13.9%AddedHolders
Q4 2023124,444$294.0K<0.1%−76,663−38.1%ReducedHolders
Q3 2023201,107$302.0K<0.1%+85,007+73.2%AddedHolders
Q2 2023116,100$202.0K<0.1%−27,000−18.9%ReducedHolders
Q1 2023143,100$180.0K<0.1%−113,900−44.3%ReducedHolders
Q4 2022257,000$779.0K<0.1%−269,300−51.2%ReducedHolders
Q3 2022526,300$290.0K<0.1%−40,100−7.1%ReducedHolders
Q2 2022566,400$339.0K<0.1%+95,800+20.4%AddedHolders
Q1 2022470,600$536.0K<0.1%−130,700−21.7%ReducedHolders
Q4 2021601,300$866.0K<0.1%+5,200+0.9%AddedHolders
Q3 2021596,100$1.30M<0.1%−161,593−21.3%ReducedHolders
Q2 2021757,693$1.76M<0.1%+131,193+20.9%AddedHolders
Q1 2021626,500$1.89M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.